The single-use syringe market is experiencing significant momentum globally due to a surge in healthcare demand, rising infection control measures, and expanding vaccination programs. These syringes, ...
Thank you for signing up! Did you know with a Digital Subscription to The Star, you can get unlimited access to the website including our premium content, as well as benefiting from fewer ads, loyalty ...
Rozanolixizumab's EU approval for self-administration methods aims to improve patient autonomy and satisfaction by minimizing clinic visits. The phase 3 MG0020 study confirmed the safety and efficacy ...
The U.S. Food and Drug Administration (FDA) on Thursday approved a new option for patients to self-inject Argenx SE’s (NASDAQ:ARGX) Vyvgart Hytrulo with a prefilled syringe (efgartigimod alfa and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback